(S)-(3-(2,6-diamino-9H-purin-9-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid

ID: ALA261240

Cas Number: 113852-35-0

PubChem CID: 72254

Max Phase: Preclinical

Molecular Formula: C9H15N6O5P

Molecular Weight: 318.23

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(N)c2ncn(C[C@@H](CO)OCP(=O)(O)O)c2n1

Standard InChI:  InChI=1S/C9H15N6O5P/c10-7-6-8(14-9(11)13-7)15(3-12-6)1-5(2-16)20-4-21(17,18)19/h3,5,16H,1-2,4H2,(H2,17,18,19)(H4,10,11,13,14)/t5-/m0/s1

Standard InChI Key:  XGTJCNSZEASLLL-YFKPBYRVSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.7954   -2.1999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2803   -1.5324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7954   -0.8650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0108   -1.1199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7037   -0.7074    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4182   -1.1199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4182   -1.9449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7037   -2.3574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0108   -1.9449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7037   -3.1824    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1326   -0.7074    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0503   -0.0804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4983    0.5327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3087    0.3612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7532    1.3174    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2012    1.9305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4562    2.7151    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7111    3.4997    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3285    2.9700    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2408    2.4601    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8607    0.9743    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  1  9  1  0
  4  9  1  0
  8 10  1  0
  6 11  1  0
 12 13  1  0
 13 14  1  0
 15 16  1  0
 17 18  2  0
 17 19  1  0
 17 20  1  0
 16 17  1  0
 13 15  1  6
 14 21  1  0
  3 12  1  0
M  END

Associated Targets(Human)

HEL (6614 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Simian virus 40 (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Camelpox virus (273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 2 (4932 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human betaherpesvirus 6 (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human betaherpesvirus 5 (5122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 318.23Molecular Weight (Monoisotopic): 318.0842AlogP: -1.50#Rotatable Bonds: 6
Polar Surface Area: 182.63Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.35CX Basic pKa: 6.56CX LogP: -5.30CX LogD: -4.72
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.39Np Likeness Score: 0.01

References

1. Lebeau I, Andrei G, Krecmerová M, De Clercq E, Holy A, Snoeck R..  (2007)  Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.,  51  (6): [PMID:17420214] [10.1128/aac.01422-06]
2. Duraffour S, Snoeck R, Krecmerová M, van Den Oord J, De Vos R, Holy A, Crance JM, Garin D, De Clercq E, Andrei G..  (2007)  Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.,  51  (12): [PMID:17893157] [10.1128/aac.00838-07]
3. Krecmerová M, Holý A, Andrei G, Pomeisl K, Tichý T, Brehová P, Masojídková M, Dracínský M, Pohl R, Laflamme G, Naesens L, Hui H, Cihlar T, Neyts J, De Clercq E, Balzarini J, Snoeck R..  (2010)  Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents.,  53  (19): [PMID:20809641] [10.1021/jm901828c]
4. Cheviet T, Lefebvre-Tournier I, Wein S, Peyrottes S..  (2019)  Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues.,  62  (18): [PMID:30964283] [10.1021/acs.jmedchem.9b00182]

Source